BMNDF (Biomind Labs) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


BMNDF Biomind Labs Inc BMNDF
30 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Biomind Labs Research & Development?

Biomind Labs BMNDF 30 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates BMNDF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Biomind Labs's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Biomind Labs  (OTCPK:BMNDF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Biomind Labs Research & Development Related Terms

Biomind Labs Research & Development Historical Data

* Premium members only.

The historical data trend for Biomind Labs's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomind Labs Research & Development Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.57 0.57 0.31 0.02 0.00

Biomind Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BMNDF
30GF Score
Biomind Labs Inc BMNDF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomind Labs Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Biomind Labs (BMNDF) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Biomind Labs and its competitors.
Is Biomind Labs' Research & Development too high?
Biomind Labs' current Research & Development is $0.00 Mil. Overall, Biomind Labs has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biomind Labs' Research & Development compare to VRTX and REGN?
Biomind Labs' Research & Development of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Biomind Labs and its competitors. Biomind Labs's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomind Labs stock overvalued right now?
Biomind Labs (BMNDF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Biomind Labs' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Biomind Labs (BMNDF), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomind Labs Business Description

Other Exchanges BMND:Canada
Address 701 West Georgia Street, Suite 515, Vancouver, BC, CAN, V7Y 1C6
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
30GF Score

Get the complete analysis for BMNDF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price